LV 216

Drug Profile

LV 216

Alternative Names: Diclofenac zinc salt

Latest Information Update: 13 Aug 2002

Price : $50

At a glance

  • Originator Vinas
  • Class Nonsteroidal anti-inflammatories; Phenylacetates
  • Mechanism of Action Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Rheumatic disorders; Rheumatoid arthritis

Most Recent Events

  • 04 Feb 1997 Preclinical development for Rheumatic disorders in USA (PO)
  • 02 Sep 1996 Preclinical development for Rheumatoid arthritis in Spain (PO)
  • 29 Aug 1996 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top